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Selective Aberration and Pigment Loss in Melanosomes of Malignant 
Melanoma Cells in Vitro by Glycosylation Inhibitors: Premelanosomes as 
Glycoprotein* 
YUTAKA MISHIMA, M.D. , PH.D. AND GENJI lMOKA w A, M.S. 
Department of Dermatology, Kobe University School of Medicine, Kobe, Japan 
We have found that glucosamine (1 mg/ml) or tunica-
mycin (0.2-0.4 1-lg/ml), specific inhibitors of lipid carrier-
dependent glycosylation of protein, when added to cul-
tured B-16 melanoma cells produce a marked loss of 
pigmentation, accompanied by distinctive. biochemical 
as well as ultrastructural aberrations in their melano-
genic compartments. Electron microscopic analysis 
shows that these newly induced unpigmented cells form 
uniquely altered melanosomes containing little or no 
melanin, although their population is not substantially 
reduced. Within the melanogenic compartments, selec-
tive aberration of melanosomes is seen, that is, deform-
ity, bulging, and segregation of their interior membrane, 
as well as the intramelanosomal formation of irregularly 
concentric lamellar structure. No apparent structural 
deformity of Golgi apparatus, Golgi-associated endo-
plasmic reticulum of lysosome (GERL), and coated vesi-
cles has been observed. · Further, no substantial altera-
tion is seen in mitochondria or other cellular structures. 
Quantitative analysis of altered and nonaltered mela-
nosomes has revealed that the ratio of altered premelan-
osomes to the total number increases to 44% in glucosa-
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dopa: L-3,4-dihydroxy-phenylalanine 
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TM: tunicamycin 
mine-treated cells and to 99.5% in tunicamycin-treated 
cells, compared to 13% in the control. 
Electron microscopic dopa reaction has also revealed 
that these altered melanosomes seem to exhibit a weakly 
positive or a negative dopa reaction in both glucosamine-
and tunicamycin-treated melanoma cells although a 
number of dopa-positive altered melanosomes are still 
seen. However, GERL and coated vesicles show no ap-
parent decrease in dopa reaction. It may be concluded 
that glycoprotein synthesis is integral to the formation 
of normal melanosomes and to their specific melanizing 
function, which could be impaired by inhibition of the 
synthesis of asparagin-linked mannose-containing sugar 
chains. This results in retrogressive changes in the pre-
melanosomal tyrosinase during its maturation process. 
In 1980, we reported much higher tyrosinase activity in the 
Golgi-associated endoplasmic reticulum of lysosome (GERL) 
and coated vesicle fraction than that in the premelanosome 
fraction of the pigment cells [1]. It has been found that tyrosin-
ase synthesized by ribosomes is condensed and activated in the 
GERL-coated vesicle system, acquiring the capacity to form 
dopa-melanin in vitro. Thus, the transfer system or the acti-
vated ty:rosinases into premelanosomes by the possible fun ction 
of coated vesicles is presumed to be necessary for the initiation 
of melanogenesis in vivo. 
T yrosinase has been shown to exist in 3 forms, T 1, T ", and T a 
in the intracellular m elanogenic compartments [2-5], depending 
on its stage of maturation, which primarily involves its glyco-
sylation. Further we have recently found the carbohydrate 
moiety of T~ possesses melanogenically essential properties 
different from those of T 1, the synthesis of which is not inter-
rupted by current glycosylation inhibitors [6]. The core se-
quence of N-glycosidically linked oligosacchar ides is a key 
structm e ofT:, tyrosinase for its melanization-inducing function 
in premelanosomes [6). 
It has been shown that the carbohydrate moieties of glyco-
proteins in various cellular membranes have a role in the 
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cellular or intracellular recognition process (7-9]. N-glycosidi-
cally linked oligosaccharide chains in hydrolytic enzymes are 
reported to function intracellularly as a signal for their transport 
into specific organelles such as lysosomes (8]. 
Although the precise association between these multiple 
forms of tyrosinase and melanosome structure is not known, it 
was stated that tyrosinase in mice is either directly or indirectly 
involved in forming the melanosome matrix (10). The above 
evidence led us to investigate the specific function of each 
melanogenic subcellular compartment such as GERL, coated 
vesicles, and premelanosomes, by their dynamics following the 
selective inhibition of glycosylation using glucosamine (Glc) 
and tunicamycin (TM). Glc [11] has been reported to inhibit 
the multiplication of various enveloped animal viruses by inter-
fering with the synthesis of viral glycoproteins. TM [12,13], a 
novel glucosamine-containing antibiotic, selectively inhibits the 
synthesis of N-acetyl-glucosaminyl-pyJ·ophosphryl-poly-iso-
prenol which is involved in the synthesis of the core sequence 
of N -glycosidically linked oligosaccharides. 
As we predicted, the addition of Glc and TM to the cultured 
B-16 melanotic melanoma cells has been found to induce un-
pigmented melanoma cells. In the present paper, marked ultra-
structural aberration and pigment Joss which are selectively 
induced in melanosomes by the glycosylation inhibitors will be 
described together with accompanying changes in the tyrosin-
ase activity of the corresponding melanogenic subcellular com-
partments. 
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FI G 1. Disappearance of the melanin pigment in a pellet of glyco-
sylation inhibitor-treated B-16 cells in comparison with those of un-
t reated B-16 cells . The cells were cul tured with the glycosylation 
inhibi tors for 11-26 days and trypsinized for pelleting. A , Glc (l mg/ 
ml)-treated B-16 ce lls ( GL+) on day 11 of cul ture in comparison with 
cont ro l B-16 cells (8 ·16 ). B , TM (0.1 , 0.2, and 0.4 !Lg/ ml)- treated B-16 
ce Lls on days 10, 22, and 26 of cultme. Dose-dependent inhibitory effect 
on pigmentation is seen. 8 · 16 =control cul ture on day 7 of culture. 
FIG 2. Light microscopi appearance of cultured B-16 melanoma 
cells . In comparison with the cont rol (a) , the glycosylation inhibi tors 
induced unpigmented cells, resulting in the loss of pigment. The dopa 
reaction is, however, distinctly positive for Glc- and TM-induced un-
pigmented cells, although 0.4 !Lg/ rnl TM-treated cells exhibit a much 
weaker reaction. a, Control B-16 ceUs. b, Glc (l mg/ ml) -induced unpig-
mented cells. c, TM (0.2 !Lg/ ml)-induced unpigmented ce lls. d, TM (0.4 
fLg/ ml) -induced unpigmented cells. e-h, Respective dopa-reacted cells. 
X 245. 
FIG 3. R epresentative premelanosomes exhibiting various degrees 
of structural a lteration which is used as the evaluation criteria fo r 
quantitative analysis of melanosome aberration induced by glycosyla-
tion inhibitors.-= Absent, 1+ = up to 3%, 2+ = 31-70%, and 3+ = 71-
100% of premelanosome field. GTA-OsO,. Bar = 1 llm. 
FIG 4. Control cultured B-16 mouse melanotic melanoma cells ex-
hibiting numerous highly melanized spheroid melanosomes (m). GTA-
OsO.,. Bar= 1/lm. Inset, Numerous partia lly melanized melanosomes 
(m) with well-developed filamentous interiors with periodicity (arrow) 
in various stages of differentiation. GTA-OsO,,. Bar = 1/lm. 
FIG 5. a, Glc-treated B-16 melanoma cells exhibi t a complete ab-
sence of melanization in the premelanosomes where a filamentous 
interior with periodicity is generally lost. These premelanosomes (pm) 
have finely granula1· homogenous in teriors wi th various degrees of 
multiconcentric lamellar figures (arrows ). GTA-OsO.,. Bar= 1/lm. b, 
Glc-induced unpigmented melanoma cells exhibi t selective aberration 
of premelanosomes (arrows). GTA-Os04 • Bar = 1 JLm. 
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FIG 6. a, Control B-16 mouse melanotic melanoma cells contain 
dopa-posit ive premelanosomes (pm) with deposition of newly formed 
dopa-melanin in the filamentous interiors with regu lar periodicity. A 
number of GERL (gl) and coated vesicles (cv) exhibit a strongly dopa-
positive reaction. GTA-dopa (37 °C, 5 h)-OsO.,. Bar = 1 f.Un. b, Glc-
induced unpigmented melanoma cells contain weakly dopa-positive 
premelanosomes (pm) in al'eas, although the premelanosomes have no 
naturally occurring mela nin. Coated vesicles (cv) still exhibit strongly 
positive dopa reaction. GTA-dopa (37 °C, 5 h) -OsO.,. Bar = 1 fLm. 
F IG 7. a, Glc- induced unpigmented melanoma cells contain strongly 
dopa-positive GERL (gl). G = Golgi apparatus. GTA-dopa (37"C, 5 
h) -OsO.,. Bar = 1 fLm. b, Glc-induced unpigmented cells retain dopa-
positive reactions in coated vesicles (cv). A fine spike structul'e (arrows) 
at theil' periphery is seen. GTA-dopa (37°C, 5 h)-OsO.,. Bar= 0.1 fLffi . 
MATERIALS AND METHODS 
Cells 
B-16 mouse melanotic melanoma cells were cultured in Eagle's 
minimal essential medium (Gibco) supplemented with 10% fetal calf 
serum (Gibco), 4 mM glutamine, 100 un its/ml penicillin, and 100 fLg/ ml 
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TABLE I. Quantitative analysis of population and structural alteration of melan.osom.es in unmelan.ized B -16 melanoma cells induced by 
glycosylation inhibitors in vitro 
Melanosomes without melan in (• 
Inhibitors Both types of mel a no- Melanosomes with Melanosomes Subclassification according to ex tent of lameUar alteration somes" melanin (• without mela-
nin" 
- 1+ 2+ 3+ 
Control 2016 645 1371 1188 80 78 26 
(100%) (32.0%) (68.0%) (86.6%) (5.8%) (5.7%) (1.9%) 
----- - ----(13.4%)------- -- -- -
Glc 1504 15 1489 838 172 308 171 
1 mg/ ml (100%) (1.0%) (99.0%) (56.3%) (11.5%) (20.7%) (11.5%) 
--------- -{43.7%)-- ----- --- . 
TM 3200 139 3061 0 12 2336 713 
0.2 Jlg/ ml (100%) (4 .4%) (95.6%) (0%) (0.4%) (76.3%) (23.3%) 
---- --- - -(100%)------ -- ---
TM 2558 123 2435 11 8 1633 783 
0.4 Jlg/ ml (100%) (4.8%) (95.2%) (0.5%) (0.3%) (67.1%) (32.1%) 
- - ---- -- --{99.5%)---- -- - - --
Abbreviations: Glc = glucosamine, TM = tunicamycin. 
"Number of melanosomes per 150 cytoplasmic 64-tun2 fie lds from d ifferent cell s. 
TABLE II. Quantitative analysis of dopa -positive prem.elanosomes and coated vesicles in un.m.elanized B-16 m.elanom.a cells induced by 
g lycosylation inhibitors 
Total number of melano-
sonles" 
Subclassification accord ing to extent of dopa reaction T ota l number of dopa · 
positive coaled vesicles" Inhibitors 
Control 
Glc 
1 mg/ ml 
TM 
0.2 Jlg/ml 
TM 
0.4/lg/ ml 
3555 
(100%) 
3001 
(100%) 
4194 
(100%) 
3527 
(100%) 
Abbreviations: Glc = glucosamine, TM = tunicamycin. 
436 
(12.3%) 
1463 
(48.8%) 
1255 
(29.9%) 
2474 
(70.1%) 
I+ 2+ 3+ 
1155 998 966 502 
(32.0%) (28.5%) (27.2%) 
-------- -{87.7%)---------
1420 117 0 605 
(47.3%) (3.9%) (0%) 
--------- -{51.2%)--- - ---- --
2925 14 0 523 
(69.7%) (0.3%) (0%) 
-------- - - (70.0%)- -- -------
488 482 82 209 
(13.8%) (13.7%) (2.3%) 
--- - - -- -- - (29.8%)-------- --
"Number of melanosomes or coated vesicles per 150 cytoplasmic 64-Jlm2 fields from different cells. 
FIG 8. Like control B-16 cells, the re are a lso a number of dopa-
negative early premelanosomes ( pm) in addition to retained dopa 
reactivity in many premelanosomes afte r Glc treatments. GTA-dopa 
(37 °C, 5 h)-Os0 ,1• Bar = 1 Jlm. 
streptomycin, at 37°C with 5% C0d 95% air atmosphere. Glucosamine 
hydrochloride was added to give a concentration of 1 mg/ ml cul ture 
medium immediately after ce ll seeding. TM experiments were carried 
out 24 h after ce ll seeding using the culture medium containing 0.1, 0.2, 
and 0.4 Jlg/ ml TM. T hereafter a ll medium was replaced with the 
inhibitor-containing fresh medium twice a week during the cell growth 
for present experiments. 
Complete loss of pigmentation was induced with a slight growth 
inhibi tion in B-16 melanoma cells after 10 days of culture in t he 
presence of 1 mg/ml Glc (Fig lA ). S imilar p igment loss has a lso been 
obtained after continuous addition of 0.1, 0.2, and 0.4 1-lg/ ml TM. The 
degree of pigment loss was parallel to the incubat ion concentrations of 
TM (Fig 1B). Corresponding to the macroscopic pigment loss, phase 
contrast light microscopic examination of unpigmented cells induced 
by Glc and TM also revealed almost complete pigment loss without 
substantia l morphologic changes of the cells (Fig 2a-d). However, dopa 
reactions [1) of these unpigmented melanoma cells induced by the 
glycosylation inhibitors a ll showed distinctly posit ive reactions (Fig 2e-
h). T hese glycosylation inhibitor'induced unpigmented melanoma cells 
have been used in this study. B iochemical characterization of these 
ce lls has been described elsewhere [6]. 
Electron Microscopy and Cytochemistry 
Cultured cells were washed twice with Hanks' balanced salt solu t ion 
and fixed in situ with 2.5% glutaraldehyde in Hanks' buffer for 60 min 
at 4 °C. After being washed twice with the buffer for 10 min, t he ce lls 
were postfixed with 1% uranyl acetate for 60 min and then 1% osmium 
tetroxide for 30 min. The cells were dehydrated with graded ethanol 
and embedded in Epon 812. For t he electron microscopic dopa reaction, 
cultured ce lls were fixed with 2.5% glu taraldehyde in Hanks' buffer for 
30 min, washed twice with the same buffer for 10 min, and incubated in 
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0.1% L-3,4-dihydroxy-phenylalanine (dopa) (Sigma Chemical Co.) so-
lution in 0.1 M phosphate buffer, pH 6.8, for 5 h at 37°C, and postfixed 
in the same manner as described above [1]. T hin sections were cut with 
a Porter-Blum MT-I ul tmtome, stained with lead citrate, and examined 
under a JOEL 100CX microscope. 
Quantitative Analysis of the Population. and S tructural A lterations 
of Melanosomes 
Electron microscopic quantitative analysis of melanosomes has been 
carried out by counting and classifying melanosomes using the following 
criteria. One hundred and fifty 64 J.tm2 cytoplasmic fields of diffe rent 
melanoma cells were counted; 64 J.tm2 comprises one field on the 
electron micrograph with 18,300 magnification. Each sample is quanti-
tatively analyzed for melanized and unmelanized melanosomes. There-
after, unmelanized melanosomes are analyzed for the degree of struc-
t UJ·al aberration by their subclassification according to the extent of the 
area occupied by abnormal lamellar or vesicular figures in their interior 
as follows (Fig 3): - = absent, + = up to 30% of premelanosome field, 
2+ = 31- 70%, and 3+ = 71-100%. 
Tyrosinase activities of premelanosomes and coated vesicles were 
evaluated by counting and classifying them according to the degree of 
dopa reactivity in 150 of the cytoplasmic fields. The degree of dopa 
reactivity of premelanosomes was evaluated by the electron density 
clue to induced dopa-melanin within their structures as follows: - = 
absent, + = slight, 2+ = moderate, 3+ = marked. 
RESULTS 
Electron Microscopy of Glc-Induced Unpigmented 
Melanoma Cells 
Electron microscopy of the control m elanoma cells shows 
t hat a large number of mela nosomes in various stages of devel-
opment are distributed ttuoughout the cytoplasm (Fig 4). Cells 
which contain only early premelanosomes in a bundance are 
scarcely seen. A well-developed Golgi apparatus and a large 
number of coated vesicles are present. 
Following 10 days of cell culture with the addition of 1 mg/ 
ml Glc immediately after seeding, m elanization in the melano-
somes of Glc-induced unpigmented melanoma cells (Fig 5) is 
seen to disappear. These m elanosomes have generally lost their 
characteristic internal membrane structures with periodicity, 
a nd show altered, rather homogenous, finely granular interiors, 
often accompanied by various degrees of a bnormal, multi con-
centric lamellar figures. 
Quantitative analysis of the population and structural alter-
ation of melanosomes (Table I) has revealed that while the 
production of melanosomes does not greatly diminish (1504 
compared to 2016 in the control) , melanizing mela nosomes 
almost completely disappear (99 .0%) after glycosylation inhi-
bition. This interrupted melanization is accompanied by the 
complete loss of normally seen periodicity of the interior mem-
brane within the melanosomes; 43.7% of those unmelanized 
melanosomes further exhibit the formulation of unique concen-
tric lamellar figures. 
Electron Microscopic Dopa Reaction of Ole-Induced 
Unpigmented M elanoma Cells 
In the control cells (Fig 6a) , induced intracytoplasmic mela n-
ization following dopa reaction is localized in th e tubular and 
cisternal portions of the smooth endoplasmic reticulum called 
GERL as well as in some premelanosomes, but not in the Golgi 
apparatus as previously found in the in vivo system [1]. In 
m elanized premelanosomes the deposition of newly form ed 
dopa-melanin after the reaction is difficult to identify. On the 
other hand, there are a pumber (12.39'; ) of dopa-negati e pre-
melanosomes [1) in spite ·of the presence of dopa-positive GERL 
and coated vesicles in the same cell (Table II) . 
In the Glc-induced unpigmented cells, despite a marked a nd 
widely distributed aberration of premelanosomes with concom-
itant loss of in vivo melanization, the reaction product, dopa-
melanin is still seen in a considerable number of the premelan-
osomes (51.2%) although the degree of th e reaction is generally 
reduced (Fig 66). However, GERL and coated vesicles reta in 
FIG 9. a., TM (0.2 J.tg/ ml) induces almost complete loss of melani-
zation throughout the premelanosomes (pm) and produces marked 
aberration of premelanosome structures such as irregular lamellar 
(double a/TOw) and vesicular (single mTows) figures. GTA-Os0,1• Bar 
= 1 J.tm. 'b, TM (0.2 J.tg/ mlY-induced unpigmented melanoma cells exhibit 
premelanosomes (pm) · with irregular lamellar and vesicular ' figures 
(double arrows ) in which a few remaining melanin particles (single 
a/TOW) are occasionally found. GTA-OsO,,. Bar= 1 J.tm. 
their dopa reactivi ty both in intensity a nd reactive population · 
(Fig 7 a,b). 
Simulating the control cell, there aTe early premelanosomes 
without dopa-melanin deposition, and moreover their numbers 
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FIG 10. TM (0.4 Jlg/ml)-induced unpigmented ·melanoma cells ex-
hibi t premelanosomes (pm) with irregula r multiconcentric lamellar 
figures (single arrows) in which a few remaining melanin particles 
(double arrows ) are occasionally found. GTA-Os04 • Bar = 1 Jlm . b, 
TM (0.4 Mg/ ml)-induced unpigmented melanoma cells exhibit preme-
lanosomes (pm) with irregular fibrous lamellar figu1·es (arrows). GTA-
OsO •. Bar = 1 Jlm. 
seem to be increased (Fig 8) . Quantitative analysis of tyrosinase 
activity in th e unpigmented cells (Table II) shows that although 
there is no abnormality of dopa-melanin deposition in its intra-
cytoplasmic localization nor its degree in GERL and coated 
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FIG 11. E lectron microscopic dopa reaction of TM (0.2 Jlg/ ml)-in-
duced unpigmented cells exhibits dopa-positive GERL ( gl) and coated 
vesicles (cu). A number of premelanosomes (pm) show weakly positive 
dopa reactions despite their structural aberration and pigment loss. 
GTA-dopa (37°C, 5 h)-OsO.,. Bar= 1 Jlm. 
vesicles, an increased number of tyrosinase-negative premelan-
osomes (48.8%) is seen parallel to an increase of altered pre-
melanosomes (43.7%) (Table I) . 
Electron Microscopy of TM-Induced Unpigmented 
Melanoma Cells 
In contrast to the untreated control cells, the cells after 
treatment with 0.2 and 0.4 J.Lg/ ml TM almost completely lose 
their partially and fully melanized melanosomes (Figs 9, 10), 
retaining only 4.4- 4.8% compared to 32.0% in the control (Table 
I) . Except for a few premelanosomes retaining relatively normal 
structure, almost all premelanosomes (99.5-100%) exhibit 
marked ultrastructural alteration, which may be described as 
unmelanized concentric lamellar type with various deg1·ees of 
asymmetricity, mult iconcentric type, multivesicular type, and 
bulging type. No apparent structural abnormalities in other 
subcellular organelles including GERL and coated vesicles are 
seen. The population density of premelanosomes is not sub-
stantially decreased. In comparison to Glc treatment (1 mg/ 
ml) , TM treatment (0 .2 or 0.4 Mg/ ml) induces more mru:ked 
premelanosome aberration with a rather empty interior. 
E lectron Microscopic Dopa Reaction of TM-Induced 
Unpigmented Melanoma Cells 
TM-induced unpigmented melanoma cells exhibit distinct 
dopa-positive reactions in GERL and coated vesicles in the 
normal range of their population, while a considerable number 
of premelanosomes (30-70%) are still dopa-positive, though 
weak, despite almost complete pigment loss and structural 
aberration in vivo (Figs 11, 12). H owever, the total number of 
unmelanized and dopa-negative premelanosomes also distinctly 
increases (30-70%) compared to the control (12.3%) (Table II) . 
A more distinct decrease in the formation of dopa-melanin after 
the reaction is seen with 0.4 J.Lg/ ml TM treatment than with 0.2 
J.Lg/ ml TM treatment. Concentric lamellar and multiconcentric 
types of premelanosomes seem to retain som e dopa reactivity, 
while multivesicular and bulging types of premelanosomes more 
often lose dopa reactivity. 
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FIG 12. a, Electron microscopic dopa reaction of TM (0.4 ,ug/ ml)-induced unpigmented cells exhibits weakly dopa-positive premelanosomes 
(pm) despite their structural aberration (arrows) and pigment loss. GTA-dopa (37°C, 5 h)-OsO.,. Bar= 1 ,um. b, Electron microscopic dopa 
reaction of TM (0.4 l'g/ rnl)-induced unpigmented cells exhibits numerous aberrated premelanosomes without (pm) and with (arrows) dopa-
induced melanin particles. GTA-dopa (37°C, 5 h)-OsO.,. Bar = 1 ,um. c, Electron microscopic dopa reaction of TM (0.4 ,ug/ rnl)-induced 
unpigmented cells exhibits strongly dopa-positive GERL ( gl) in the vicinity of the Golgi apparatus (G) despite the fact that abenated bulging 
premelanosomes (pm) exhibit no or scarcely any positive dopa reactivity. GTA-dopa (37°C, 5 h)-OsO.,. Bar= 1 ,um. 
DISCUSSION 
The melanogenic function of tyrosinase may be divided into 
2 different stages of maturation. Melanization proceeds only in 
premelanosomes in vivo, while the GERL-coated vesicle system 
possesses the capacity to form dopa-melanin in vitro. The 
intracellular events found in the glycosylation inhibitor-induced 
interrupted melanogenesis are (1) loss of melanin in melano-
somes, (2) the number of premelanosomes formed does not 
greatly decrease, (3) marked selective abenation of the melan-
osome structw-e, (4) GERL and coated vesicles retain their 
tyrosinase activity capable of forming dopa-melanin in vitro. In 
order to correlate further these electron microscopic observa-
tions with the biochemical findings [6], we have undertaken 
quantitative analysis of. the status of melanogenesis in the 
various subcellular compartments before and after glycosyla-
tion inhibitor treatments. It has been found that although Glc 
and TM produce up to 99% and 95.2% unpigmented premelan-
osomes, respectively, approximately 1/2 and %, respectively, of 
these unpigmented premelanosomes are found to be still dopa-
positive suggesting disturbed maturation of tyrosinase to ac-
quire an in vivo melanizing function in melanosomes. 
114 MISHIMA AND IMOKA W A 
In addition, dopa-negative unmelanized premelanosomes in-
crease from 12.3% to 48.8% and 70.1% after treatment with Glc 
and TM, respectively. 
In analyzing the genesis of almost complete inhibition of 
melanization in premelanosomes by the inhibitors, it may be 
noted that carbohydrate-r ich T 3 is reported to be only a form 
of tyrosinase in membrane-bound conditions, and is capable of 
melanization in the specialized membranous structure [3). Our 
parallel biochemical studies [6] reveal a loss or marked decrease 
of T 3 in the melanosome-containing fraction as well as in the 
small-granule fractions despite no decrease in the total tyrosin-
ase activity in this experimental system . Quevedo [10] reported 
that in most cases where T 2 and T 3 are reduced or absent within 
hair bulbs of mice, the matrix of the melanosome exhibits 
significant defects in the ultrastructme. Fmthermore, the hy-
popigmentation of tyrosinase-positive oculocutaneous albinism 
[14] and Chediak-Higashi syndrome [15] have been reported to 
be related to a defective function of the melanosome membrane. 
Thus it seems reasonable to assume that T, and T 3 ar e both 
able to form dopa-melanin in vitro as seen in the GERLs, 
coated vesicles, and premelanosomes, while in vivo melaniza-
tion requires T 3 and its specific activation by the function of 
the melanosome membrane. 
Concerning the increased ratio of dopa-negative premelano-
somes to the total number of premelanosomes, it can be hy-
pothesized that the inhibitors cause the par tial interruption in 
tyrosinase transfer to premelanosomes from GERLs and coated 
vesicles which lose T 3 but still contain preactiva ted dopa-posi-
t ive T, tyrosinase even after the treatments. This inten-upted 
transfer may be due to the observed structm al alteration in the 
melanosomal membrane which results in the abolishment of 
the tyrosinase-accepting function, possibly the tyrosinase recep-
tor. 
Recent investigations in the function of sugar chains of mem-
brane surface glycoprotein provide increasing evidence of their 
role as signals for secretion, fusion, transportation, and receptor 
functions in various cellular events [7-9). It should be men-
tioned that in our experimental system the incorporation rate 
of eHJ-mannose is highest in melanosomal fractions with 3-fold 
of the total cells and this high incorporation can be inhibited 
by the glycosylation inhibitors [6). 
The specific function of th e outer limiting as well as inner 
membranous structures of melanosomes has been the subject 
for speculation in the past. However, little evidence is provided. 
Thus, the specific effects of the marked structural alteration of 
melanosomes, induced by glycosylation inhibitors, would pro-
vide notable informat ion. It has also been shown that carbo-
hydrates contribute to the structure of the premelanosomal 
matrix [16). Our present evidence seems to suggest that struc-
tmally impaired premelanosomes still can receive transportable 
tyrosinase to som e extent, as seen by the dopa reaction, but the 
TM- or Glc-induced unmelanized cells have lost their ability 
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presumably in GERL to form mature tyrosinase capable of in 
vivo melanization. 
The above evidence, together with biochemical findings re-
garding T 3 and total tyrosinase activity [6], would indicate that 
glycoprotein synthesis is an integral part of the normal structme 
of melanosomes and their specific function, which could be 
impaired by the inhibition of the synthesis of the asparagin-
linked mannose-containing sugar chain. This impairment is 
accompanied by retrogressive changes in the premelanosomal 
tyrosinase to that of GERL-coated vesicles, dming its matura-
t ion process, losing in vivo melanizing capacity. 
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